MARIA ROSAL SANCHEZ: Open Payments
NPI 1669129250 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$798 in 34 payments from 21 companies in 2025. Trend: 2023 $991 · 2024 $1,149 · 2025 $798
Food & beverage: $621Education: $177
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $113 |
| SEAGEN INC. | 1 | $93 |
| GENZYME CORPORATION | 3 | $79 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| Sequel Med Tech, LLC | 2 | $59 |
| PFIZER INC. | 3 | $40 |
| Janssen Biotech, Inc. | 2 | $35 |
| Aveo Pharmaceuticals, Inc. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Eisai Inc. | 2 | $31 |
Products named: VENCLEXTA, SARCLISA, TWIIST, KISQALI, FOTIVDA, Lenvima, ZENPEP, SCEMBLIX.
Industry payments across AR — which companies pay providers there.
